диссертации / 131

102. Lin, G. Cholecystectomy and risk of pancreatic cancer: a meta-analysis of observationalstudies / Z. Zeng, X. Wang, G. Lin et al // Cancer Causes Control. - 2012. – Vol. 23(1). – P. 59–67.

103. Luo, J. Women’s Health Initiative Investigators Adami. Women’

shealthinitiative investigators. Obesityandrisk of pancreatic cancer among postmenopausal women: the Women’s Health Ini-tiative (UnitedStates) / K. Margolis, H. Adami, A. La Croix, W. Ye, J. Luo //Br J Cancer. - 2008. – Vol. 99(3). – P. 527–531.

104. Luttges, J. Clear cell carcinoma of the pancreas: an adenocarcinoma with

ductal phenotype / I. Vogel, M. Menke, J. Luttges et al // Histopathology. - 1998. – Vol. 32. – P.444-448.

105. Luttges, J. The grade of pancreatic ductal carcinomas is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation /S. Schemm, I. Vogel, J. Luttges et al // J Pathol. - 2000. - Vol. 191. - P. 154-161.

106. Magistrelli, P. Prognostic factors after surgical resection for pancreatic carcinoma / A. Antinori,A. Crucitti, P. Magistrelli et al // J Surg Oncol. - 2000. – Vol. 74. – P.36-40.

107.Malka, D. Risk of pancreatic adenocarcinoma in chronic pancreatitis / P. Hammel, F. Maire, D. Malka et al // Gut. - 2002. - 51849–852.852.

108.Malvezzi, M. European cancer mortality predictions for the year 2012 / P. Bertuccio, F. Levi, M. Malvezzi et al // Ann Oncol. - 2012. – Vol. 23. – P. 1044–

1052.

111

109. Mancuso, A. Current therapies and advances in the treatment of pancreatic cancer / F. Calabrò,C. Sternberg, A. Mancuso // Crit Rev Oncol Hematol. - 2006.

– Vol. 58. – P. 231-241.

110. Matsuno, S. Surgical treatment of carcinoma of the pancreas. Experience in 272 patients / T. Sato, S. Matsuno // Am J Surg. - 1986. – Vol. 152. – P. 499-504.

111. Meyer, W. Pathomorphological and histological prognostic factors in

curatively resected ductal adenocarcinoma of the pancreas / C. Jurowich, M. Reichel, W. Meyer et al // Surg Today. - 2000. – Vol. 30. – P.582-587.

112.Michaud, D. Alcohol in take and pancreatic cancer: apooled analysis from the pancreatic cancer cohortconsortium (PanScan) / A.Vrieling, L. Jiao, D. Michaud et al. // Cancer Causes Control. - 2010. – Vol. 21(8). – P. 1213–1225.

113.Moll, R. Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors/ R. Moll // Subcell Biochem. - 1998. – Vol.31. – P. 255-262.

114.Moon H., Predicting survival after surgical resection for pancreatic ductal adenocarcinoma/ J. An, J. Heo, H. Moon et al //Pancreas. - 2006. – Vol. 32. – P. 37-43.

115.Moon, H. A result of surgical treatment for ductal adenocarcinoma of the head of the pancreas / K. Jang, J. Heo, H. Moon et al // Korean J Gastroenterol. - 2003. – Vol. 42. – P. 156-163.

116. Morohoshi, T. Immunocytochemical markers of uncommon pancreatic tumors. Acinar cell carcinoma, pancreatoblastoma, and solid cystic (papillarycystic) tumor /M. Kanda, A. Horie, T. Morohoshi et al // Cancer. - 1987. – Vol. 59. – P. 739-747.

112

117. Nagakawa, T. Surgical treatment of pancreatic cancer. The Japanese experience /I. Konishi, K. Ueno, T. Nagakawa et al // Int J Pancreatol. - 1991. – Vol. 9. – P. 135-145.

118. Nakao, A. Lymph node metastasis in carcinoma of the body and tail of the pancreas / A. Harada, T. Nonami, A. Nakao et al //Br J Surg. - 1997. – Vol. 84. – P.1090-1092.

119.National Cancer Institute// Bethesda(MD). - 2013. - Available from: http://seer.cancer.gov/csr/1975_2010.

120.Navas, C. 3EGF Receptor Signaling Is Essential for K-Ras Oncogene-

121. Ornellas, A. Prognostic factors in renal cell carcinoma: analysis of 227 patients treated at the Brazilian National Cancer Institute/ D. Andrade, P. Ornellas, A. Ornellas et al // Int Braz J Urol. – 2012. - Vol. 38(2). – P. 185-194.

122. Ozaki, H.The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection / T. Hiraoka, R. Mizumoto, H. Ozaki et al // Surg Today. – 1999. – Vol. 29. – P. 1622.

123.Paal, E. A clinic-pathologic and immunogistochemical study of 35 anaplastic carcinomas of the pancreas with a review of the literature / L. Thompson, R. Frommelt et al // Ann Diagn Pathol. – 2001. – Vol. 5. – P.129-140.

124.Pannala, R. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus/ J. Leirness, W. Bamlet, R. Pannala et al // Gastroenterology. - 2008. – Vol. 134(4). – P. 981–987.

113

125.Parkin, D. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010 / L. Boyd, L. Walker, D. Parkin // Br J Cancer. – 2011. - Vol. 105 (Suppl 2). – P. 77–81.

126.Parkin, D. The fraction of cancer attributable to lifestyle and environmental factors inthe UK in 2010 / D. Parkin // Br J Cancer. - 2011. – Vol. 105 (Suppl 2).

– P. 2–5.

127. Pedrazzoli, S. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy study group / . V. Di Carlo, R. Dionigi, S. Pedrazzoli et al //Ann Surg. - 1998. – Vol. 228. – P. 508-517.

128.Risch, H. ABO blood group, Helicobacterpylori seropositivity, and risk of pancreatic cancer: a case-controlstudy / H/ Yu, L. Lu, M. Kidd, H. Risch // J Natl Cancer Inst. - 2010. – Vol. 102(7). – P. 502–505.

129.Schneider, G. Pancreatic cancer: basic and clinical aspects / J. Siveke, F. Eckel, G. Schneider et al // Gastroenterology. – 2005. – Suppl.128. – P.1606–1625.

130.Scholzen, T. The Ki-67 protein: from the known and the unknown / J. Gerdes, T. Scholzen // J Cell Physiol. - 2000. – Vol. 152(3). – P.311-322.

131.Seok, J. Expression of Ki-67, p53, and K-ras in chronic pancreatitis and pancreatic ductal adenocarcinoma / H. Don, J. Lee, J. Seok et al // World J Gastroenterol. - 2005. - Vol. (November 21)11(43). – P. 6765-6769.

132.Serra, S. Revision 2: an immunohistochemical approachand evaluation of solid pseudopapill ary tumour of thepancreas / R. Chetty, S. Serra // J Clin Pathol. - 2008. – Vol. 61. – P. 1153-1159.

114

133.Sessa, F. Ductal cancers of the pancreas frequently express markers of gastrointestinal epithelial cells./ M. Bonato, B. Frigerio, F. Sessa et al // Gastroenterology.-1990.- P. 1655-1665.

134.Seufferlein, T. Pancreatic adenocarcinoma: ESMO–ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up / E. Cutsem, P. Rougier, T. Seufferlein // Annals of Oncology 23. – 2012. - Suppl 7. – P.33–40.

135.Shimada, K. Reappraisal of the clinical significance of tumor size in patients with pancreatic ductal carcinoma / Y. Sakamoto, T. Sano, K. Shimada et al // Pancreas. - 2006. – Vol. 33. – P.233-239.

136.Shimada, K. Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail / Y. Sakamoto, T. Sano, T. Kosuge, K. Shimada // Surgery. - 2006. – Vol. 139. – P. 288-295.

137.Shoup, M. Is extended resection for adenocarcinoma of the body or tail of the pancreas justified / K. Conlon, D. Klimstra, M. Brennan, M. Shoup // J Gastrointest Surg. - 2003. – Vol. 7. – P.946-952.

138.Sierzega, M. Theratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with nodepositive pancreatic head cancer / T. Popiela, J. Kulig, K. Nowak, M. Sierzega // Pancreas. - 2006. – Vol. 33. – P. 240-245.

139.Silverman, D. Why do Black Americans have a higher risk of pancreatic cancer than White Americans / R. Hoover, L. Brown, D. Silverman et al // Epidemiology. - 2003. – Vol. 14(1). – P. 45–54.

140.Sohn, T. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators / C. Yeo, J. Cameron, T. Sohn et al // J Gastrointest Surg. - 2000. – Vol. 4. – P. 567-579.

115

141.Solcia, E. Tumours of the Pancreas / C. Capella, G. Kloppel, E. Solcia // AFIP. – 1997. – Washington.-P.541.

142.Sperti, C. Ductal adenocarcinoma of the pancreas: clinicopathologic features and survival / B. Bonadimani, C. Pasquali, C. Sperti // Tumori. - 1993. – Vol. 79.

– Vol. – P. 325-330.

143. Sperti, C. Recurrence after resection for ductal adenocarcinoma of the pancreas / S. Pedrazzoli, A. Piccoli, C. Pasquali, C. Sperti // World J Surg. - 1997.

– Vol. 21. – P. 195-200.

144.Sperti, C. Survival after resection for ductal adenocarcinoma of the pancreas / S. Pedrazzoli, A. Piccoli, C. Pasquali, C. Sperti // Br J Surg. - 1996. – Vol. 83. – P. 625-631.

145.Stattin, P. Prospective study of hyperglycemia and cancer risk /O. Bjor, P. Ferrari, P. Stattin et al// Diabetes Care. - 2007. – Vol. 30(3). – P. 561–567.

146.Stocks, T. Bloodglucose and risk of incident and fatal cancer in themetabolic syndrome and cancerproject (me-can): analysis of six prospective cohorts / K.

Rapp, T. Bjorge, T. Stocks et al //P Lo S Med. - 2009. – Vol. 6(12). - e1000201.

147.Stolzenberg-Solomon, R. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers /B. Graubard, S. Chari, R. Stolzenberg-Solomon et al // JAMA. - 2005. – Vol. 294(22). – P. 2872–2878.

148.Su, G. Germline and somatic mutations of the STK11/LKB1 Peutz Jeghers gene in pancreatic and biliary cancers /R. Hruban, R. Bansal, G. Su et al//Am J Pathol. - 1999. 1541835–1840.1840.

116

149.Suzuki, K. Prognostic Significance of High Nuclear Grade in Patients with Pathologic T1a Renal Cell Carcinoma / R. Mizuno, S. Mikami, K. Suzuki et al// Jpn J Clin Oncol. – 2012. – P.117.

150.Tada, M. Analysis of Kraus gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease / M. Ohashi, Y. Shiratori, M. Tada et al // Gastroenterology. - 1996. - 110227–231.231.

151.Takada, T. A search for prognostic factors in cancer of the pancreatic head: the significance of the DNA ploidy pattern / H. Yasuda, T. Takada // Surg Oncol. - 1995. – Vol. 4. – P. 237-243.

152.Takahashi, T. Predictive factors for long-term survival in patients with pancreatic carcinoma / N. Niino, H. Ishikura, T. Takahashi et al// Hepatogastroenterology. - 1997. – Vol. 44. – P. 1463-1468.

153.Takai, S. Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience /

S. Satoi, H. Toyokawa, S, Takai et al// Pancreas. - 2003. – Vol. 26. – P.243-249.

154.Talamini, G. Alcohol and smoking as risk factors in chronic pancreatitis and pancreatic cancer /C.Bassi, M, Falconi, G. Talamini et al// Dig Dis Sci. - 1999. –

Vol. 44. – P. 1303–1311.

155.Tanimura, A. Carcinoma in heterotopic gastric pancreas / H. Yamamoto, H. Shibata, E. Sano, A. Tanimura // Acta Pathol Jpn. - 1979. – Vol. 29. – P. 251-257.

156.Tomaszewska, R. Proliferation index and karyometric features of pancreatic intraductal proliferative lesions / K. Okon, K. Nowak, J. Stachura, R. Tomaszewska // Anal Cell Pathol. - 1999. – Vol. 19. – P. 175–185.

117

157. Tramacere, I. Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation / L. Scotti, M. Jenab, I. Tramacere et al// Int J Cancer. - 2010.

– Vol. 126(6). – P. 1474–1486.

158.Trede, M. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality / G. Schwall, H. Saeger, M. Trede //Ann Surg. - 1990. – Vol. 211. – P. 447-448.

159.Tsao, J. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation / R. Rossi, J. Lowell, J. Tsao // Arch Surg. - 1994. – Vol. 129. – P. 405-

160.Tschang, T. Pleomorphic carcinoma of the pancreas: an analisis of 15 cases / R. Garza-Garza, J. Kissane, T, Tschang //Cancer. – 1977. – Vol. 39. – P. 21142126.

161.Tsuchiya, R. Collective review of small carcinomas of the pancreas /T. Noda, N. Harada, R. Tsuchiya et al // Ann Surg. - 1986. – Vol. 203. – P. 77-81.

162.Turati, F. A meta-analysis of coffee consumption and pancreatic cancer/ C. Galeone, V. Edefonti, F. Turati et al // AnnOncol. - 2012. – Vol. 23(2). – P.311–

318.

163.Van Geenen, R. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update/ T. van Gulik, G. Offerhaus, R. Van Geenen // Eur J Surg Oncol. - 2001. – Vol. 27. – P. 549-551.

164.Vrieling, A. Fruit and vegetable consumption and pancreatic cancer risk in the European prospective investigation into cancer and nutrition / B. Verhage, F. van Duijnhoven, A. Vrieling et al// IntJCancer. - 2009. – Vol. 124(8). – P. 1926–

1934.

118

165.Wagner, M. Curative resection is the single mostimportant factor determining outcome in patients with pancreatic adenocarcinoma / C. Redaelli, M. Lietz, M. Wagner et al // Br J Surg. - 2004. – Vol. 91. – P.586-594.

166.Walter, M. Direct Correlation between Proliferative Activity and Dysplasia in Pancreatic Intraepithelial Neoplasia (PanIN): Additional Evidence for a Recently Proposed Model of Progression / M. Klein, H. Ralph, H. Hruban, M. Walter et al // Mod Pathol. - 2002. – Vol. 15(4). – P. 441–447.

167.Weger, A. Nuclear DNA distribution pattern of the parenchymal cells in adenocarcinomas of the pancreas and in chronic pancreatitis. A study of archival specimens using both image and flowcytometry / U. Falkmer, G. Schwab, A. Weger et al // Gastroenterology. - 1990. - Vol. 99. - P. 237-242.

168.Wenger, F. Prognosis factors in carcinoma of the head of the pancreas / F. Peter, J. Zieren, F. Wenger et al // Dig Surg. - 2000. – Vol. 17. – P. 29-35.

169.Wilenz, R. Loss of expression in Dpc4 in pancreatic intraepithelial neoplasia

(PanIN): evidence that DPC4 inactivation occurs late in neoplastic progression / C. Iacobuzio–Donahue, P. Argani, R. Wilenz // Cancer Res. - 2000. – Vol. 60. – P. 2002–2006.

170.World Health Organization //World Health Organization Statistical Information System// WHO Mortality Database. - 2012. - Available from:http://www3.who. int/whosis/menu.cfm.

171.Wu, T The role of bcl-2, p53, and Ki-67 index in predicting tumor recurrens for low grade superficial transitional cell bladder carcinoma/ J. Chen J, Y. Lee, J. Huang, T. Wu// J.Urol. - 2000. - Vol. 163 (3). – P. 758-760.

119

172.Yeo, C. Pancreaticoduodenectomy for cancer of the head of the pancreas.

201patients / J. Cameron, K. Lillemoe, C. Yeo et al //Ann Surg. - 1995. – Vol.

221.– P. 721-731.

173.Yeo, C. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome / J. Cameron, T. Sohn. C. Yeo et al// Ann Surg. - 1999. – Vol. 229. – P. 613-622.

174.Zamboni G. Cystic neoplasms of the pancreas with mucin-production /G. Zamboni // Am J Surg Pathol. – 1999. – Vol. 23. – P. 410-22. 25.

175 Zheng, W. Well-done meat intake, heterocyclic amine exposure, and cancer

risk/ S. Lee, W. Zheng // Nutr Cancer. - 2009. – Vol. 61. – P. 437-446.

120